ARTICLE | Company News
Lexicon Genetics Inc., GlaxoSmithKline deal
August 20, 2001 7:00 AM UTC
GSK received a non-exclusive sublicense to LEXG's gene targeting technologies, for use in the pharma company's internal research programs. LEXG will receive an upfront technology and license payment. ...